Ahmed E. Goda
-
- NF-κB Signaling Pathways 3
- Pharmacology top 10%
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems 3
-
- Cell death mechanisms and regulation 6
-
- Cancer-related Molecular Pathways 4
-
- Cancer Research and Treatments 2
-
- Electron Spin Resonance Studies 2
-
- COVID-19 Clinical Research Studies 2
-
- Estrogen and related hormone effects 2
- Co-authors
- Toshiyuki SakaiMano HorinakaMiki WakadaTatsushi YoshidaTakashi YasudaHiroya TaniguchiMasako KonishiAlaa E. El‐Sisi
- Partner nations
- EgyptJapanUnited States
In The Last Decade
Ahmed E. Goda
22 papers receiving 586 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 90
- Drug Discovery 1
- Pharmacology 99
- Biochemistry 35
- Pharmaceutical Science 31
Countries citing papers authored by Ahmed E. Goda
This map shows the geographic impact of Ahmed E. Goda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed E. Goda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed E. Goda more than expected).
Fields of papers citing papers by Ahmed E. Goda
This network shows the impact of papers produced by Ahmed E. Goda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed E. Goda. The network helps show where Ahmed E. Goda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ahmed E. Goda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 3 | |
| 2 | 2022 | 5 | |
| 3 | 2022 | 6 | |
| 4 | 2021 | 33 | |
| 5 | 2021 | 12 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 10 | |
| 9 | 2018 | 46 | |
| 10 | Induction of G1 Arrest by SB265610 Involves Cyclin D3 Down-regulation and Suppression of CDK2 (Thr160) Phosphorylation. | 2015 | 2 |
| 11 | 2014 | 15 | |
| 12 | 2013 | 3 | |
| 13 | 2013 | 25 | |
| 14 | 2012 | 32 | |
| 15 | 2010 | 23 | |
| 16 | 2008 | 100 | |
| 17 | 2008 | 24 | |
| 18 | 2008 | 122 | |
| 19 | 2007 | 19 | |
| 20 | 2004 | 58 |
About Ahmed E. Goda
Ahmed E. Goda is a scholar working on Pharmaceutical Science, Biophysics and Cancer Research, having authored 22 papers that have together received 604 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (6 papers), Cancer-related Molecular Pathways (4 papers), NF-κB Signaling Pathways (3 papers), Advanced Drug Delivery Systems (3 papers), Cancer Research and Treatments (2 papers), Electron Spin Resonance Studies (2 papers), COVID-19 Clinical Research Studies (2 papers) and Estrogen and related hormone effects (2 papers). The work is most often cited by research in Cancer Research (90 citations), Drug Discovery (1 citation) and Pharmacology (99 citations). Ahmed E. Goda has collaborated with scholars based in Egypt, Japan and United States. Frequent co-authors include Toshiyuki Sakai, Mano Horinaka, Miki Wakada, Tatsushi Yoshida, Takashi Yasuda, Hiroya Taniguchi, Masako Konishi, Alaa E. El‐Sisi, Keisho Kataoka and Toshikazu Yoshikawa. Their work appears in journals such as Cancer Research, Oncogene and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.